MedPath

HSA Approvals

Singapore Health Sciences Authority approved drug registrations and therapeutic product information

Health Sciences Authority
Singapore
5,858 Approvals
Showing 581 to 600 of 5,858 approvalsPage 30 of 293

ROSWERA FILM-COATED TABLETS 20MG

Approval Number: SIN16657P
Approval: Dec 29, 2022

ROSWERA FILM-COATED TABLETS 10MG

Approval Number: SIN16658P
Approval: Dec 29, 2022

VORICONAZOLE MYLAN POWDER FOR SOLUTION FOR INJECTION 200 MG/VIAL

Approval Number: SIN16656P
Approval: Dec 20, 2022
mylan pharmaceuticals pte. ltd.

ROYCE RIFAMPICIN CAPSULE 150MG

Approval Number: SIN16652P
Approval: Dec 7, 2022

ROYCE RIFAMPICIN CAPSULE 300MG

Approval Number: SIN16653P
Approval: Dec 7, 2022

SERNADE FILM-COATED TABLET 50 MG

Approval Number: SIN16649P
Approval: Dec 1, 2022

CO-MIDIS TABLETS 80MG/5MG

Approval Number: SIN16647P
Approval: Nov 24, 2022

EXEDRAL 25 FILM-COATED TABLET 25MG

Approval Number: SIN16646P
Approval: Nov 22, 2022

HIBRUKA TABLET 50MG

Approval Number: SIN16645P
Approval: Nov 22, 2022

AXCEL CEPHALEXIN-250 CAPSULE 250MG

Approval Number: SIN16644P
Approval: Nov 21, 2022

TELCORD 80 TABLET 80 MG

Approval Number: SIN16639P
Approval: Nov 11, 2022

TELCORD 40 TABLET 40 MG

Approval Number: SIN16640P
Approval: Nov 11, 2022

L-ASCAIN SOLUTION FOR INJECTION 5MG/ML

Approval Number: SIN16641P
Approval: Nov 11, 2022

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.